These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29351965)

  • 1. Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants.
    Dickerson JF; Lynch FL; Leo MC; DeBar LL; Pearson J; Clarke GN
    Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29351965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Preventing Depression Among At-Risk Youths: Postintervention and 2-Year Follow-Up.
    Lynch FL; Dickerson JF; Clarke GN; Beardslee WR; Weersing VR; Gladstone TRG; Porta G; Brent DA; Mark TL; DeBar LL; Hollon SD; Garber J
    Psychiatr Serv; 2019 Apr; 70(4):279-286. PubMed ID: 30929618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
    Wiles NJ; Thomas L; Turner N; Garfield K; Kounali D; Campbell J; Kessler D; Kuyken W; Lewis G; Morrison J; Williams C; Peters TJ; Hollinghurst S
    Lancet Psychiatry; 2016 Feb; 3(2):137-44. PubMed ID: 26777773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits.
    Yan C; Rittenbach K; Souri S; Silverstone PH
    BMC Psychiatry; 2019 Aug; 19(1):240. PubMed ID: 31382932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
    Lynch FL; Dickerson JF; Clarke G; Vitiello B; Porta G; Wagner KD; Emslie G; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes T; DeBar L; McCracken JT; Strober M; Suddath RL; Spirito A; Onorato M; Zelazny J; Iyengar S; Brent D
    Arch Gen Psychiatry; 2011 Mar; 68(3):253-62. PubMed ID: 21383263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of internet-mediated cognitive behavioural therapy for depression in the primary care setting: results based on a controlled trial.
    Holst A; Björkelund C; Metsini A; Madsen JH; Hange D; Petersson EL; Eriksson MC; Kivi M; Andersson PÅ; Svensson M
    BMJ Open; 2018 Jun; 8(6):e019716. PubMed ID: 29903785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost effectiveness of cognitive behavioral therapy (CBT) in clinically depressed adolescents: individual CBT versus treatment as usual (TAU).
    Stikkelbroek Y; Bodden DH; Deković M; van Baar AL
    BMC Psychiatry; 2013 Nov; 13():314. PubMed ID: 24261913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review.
    Li M; Bai F; Yao L; Qin Y; Chen K; Xin T; Ma X; Ma Y; Zhou Y; Dai H; Li R; Li X; Yang K
    Value Health; 2022 Jun; 25(6):1030-1041. PubMed ID: 35422392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a randomized trial to treat depression among Latinos.
    Kafali N; Cook B; Canino G; Alegria M
    J Ment Health Policy Econ; 2014 Jun; 17(2):41-50. PubMed ID: 25153092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome.
    Sampaio F; Bonnert M; Olén O; Hedman E; Lalouni M; Lenhard F; Ljótsson B; Ssegonja R; Serlachius E; Feldman I
    BMJ Open; 2019 Jan; 9(1):e023881. PubMed ID: 30679293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).
    Chernyak N; Petrak F; Plack K; Hautzinger M; Müller MJ; Giani G; Icks A
    BMC Geriatr; 2009 Jul; 9():25. PubMed ID: 19570236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model.
    Ross EL; Vijan S; Miller EM; Valenstein M; Zivin K
    Ann Intern Med; 2019 Dec; 171(11):785-795. PubMed ID: 31658472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of cognitive behaviour therapy versus talking and usual care for depressed older people in primary care.
    Holman AJ; Serfaty MA; Leurent BE; King MB
    BMC Health Serv Res; 2011 Feb; 11():33. PubMed ID: 21314920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of guided self-help treatment for recurrent binge eating.
    Lynch FL; Striegel-Moore RH; Dickerson JF; Perrin N; Debar L; Wilson GT; Kraemer HC
    J Consult Clin Psychol; 2010 Jun; 78(3):322-33. PubMed ID: 20515208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
    Hollinghurst S; Carroll FE; Abel A; Campbell J; Garland A; Jerrom B; Kessler D; Kuyken W; Morrison J; Ridgway N; Thomas L; Turner K; Williams C; Peters TJ; Lewis G; Wiles N
    Br J Psychiatry; 2014 Jan; 204(1):69-76. PubMed ID: 24262818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Different Formats for Delivery of Cognitive Behavioral Therapy for Depression: A Systematic Review Based Economic Model.
    Wu Q; Li J; Parrott S; López-López JA; Davies SR; Caldwell DM; Churchill RC; Peters TJ; Lewis G; Tallon D; Dawson S; Taylor A; Kessler DS; Wiles N; Welton NJ
    Value Health; 2020 Dec; 23(12):1662-1670. PubMed ID: 33248522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings.
    Sado M; Koreki A; Ninomiya A; Kurata C; Mitsuda D; Sato Y; Kikuchi T; Fujisawa D; Ono Y; Mimura M; Nakagawa A
    Psychiatry Clin Neurosci; 2021 Nov; 75(11):341-350. PubMed ID: 34459077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Evaluation of Collaborative Care for Diabetes and Depression in Primary Care.
    Johnson JA; Lier DA; Soprovich A; Al Sayah F; Qiu W; Majumdar SR
    Am J Prev Med; 2016 Jul; 51(1):e13-20. PubMed ID: 26947212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Analysis of Trauma-Focused Cognitive Behavioral Therapy: A Randomized Control Trial among Norwegian Youth.
    Aas E; Iversen T; Holt T; Ormhaug SM; Jensen TK
    J Clin Child Adolesc Psychol; 2019; 48(sup1):S298-S311. PubMed ID: 29877724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial.
    Hollinghurst S; Peters TJ; Kaur S; Wiles N; Lewis G; Kessler D
    Br J Psychiatry; 2010 Oct; 197(4):297-304. PubMed ID: 20884953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.